What This Document Is
This document provides a focused overview of key concepts related to pharmacological interventions for bone, joint, and sensory conditions – topics central to the NUR 312 Pharmacology course at La Salle University. It’s designed as a quick reference to support understanding of medication classes, patient considerations, and associated lab values within these therapeutic areas.
Why This Document Matters
This resource is particularly valuable for nursing students preparing for exams, clinical rotations, or needing a consolidated review of essential pharmacology principles related to musculoskeletal and sensory health. It’s most useful when studying for assessments covering osteoporosis, arthritis, and gout, and when preparing to administer related medications. This document exists to bridge the gap between comprehensive course materials and practical application of pharmacological knowledge.
Common Limitations or Challenges
This document is *not* a substitute for a thorough understanding of the underlying pathophysiology, detailed drug monographs, or clinical judgment. It does not provide complete dosage calculations, detailed nursing care plans, or cover all possible drug interactions. It’s a preview intended to highlight core information, not to provide exhaustive instruction.
What This Document Provides
This document includes:
* Recommended daily allowance for Calcium and considerations for specific populations.
* Key risk factors and pathological processes related to osteoporosis, including definitions of osteopenia and pre-osteoporosis.
* A table summarizing essential information for medications used to treat osteoporosis: Estrogen, Raloxifene, Calcitonin, and Bisphosphonates – including precautions, adverse reactions, nursing considerations, and associated labs.
* An overview of therapeutic approaches to Osteoarthritis and Rheumatoid Arthritis, including the role of Acetaminophen, NSAIDs, and Corticosteroids.
* A summary of medications used to treat Rheumatoid Arthritis, including Methotrexate, Monoclonal Antibodies (Adalimumab, Infliximab), and Hydroxychloroquine – with details on precautions, nursing considerations, and associated labs.
* Information on Gout, including dietary considerations and a preview of pharmacological interventions.
This preview does *not* include detailed treatment protocols, comprehensive drug monographs, or in-depth discussions of disease pathology beyond what is necessary to understand the medication’s role. It also does not cover all medications within each class.